We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
11176
PUT
Alaunos Therapeutics
TCRT
$4.71M
$271K ﹤0.01%
992
+232
+31% +$70.9K
ATNX
11177
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$271K ﹤0.01%
4,500
-1,785
-28% -$130K
SSAAW
11178
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$271K ﹤0.01%
387,132
+186,300
+93% +$148K
AMZA icon
11179
InfraCap MLP ETF
AMZA
$484M
$270K ﹤0.01%
+10,345
New +$273K
ARQT icon
11180
PUT
Arcutis Biotherapeutics
ARQT
$3.29B
$270K ﹤0.01%
11,300
+2,600
+30% +$59.3K
GTX icon
11181
PUT
Garrett Motion
GTX
$5.41B
$270K ﹤0.01%
+36,700
New +$264K
IDRV icon
11182
PUT
iShares Self-Driving EV and Tech ETF
IDRV
$139M
$270K ﹤0.01%
+5,600
New +$277K
INOD icon
11183
Innodata
INOD
$2.09B
$270K ﹤0.01%
28,342
+2,280
+9% +$17.5K
LFMD icon
11184
LifeMD
LFMD
$166M
$270K ﹤0.01%
43,464
-49,080
-53% -$419K
NKTX icon
11185
PUT
Nkarta
NKTX
$167M
$270K ﹤0.01%
9,700
-38,100
-80% -$1.21M
NTST
11186
NETSTREIT Corp
NTST
$2.1B
$270K ﹤0.01%
+11,400
New +$288K
OTLK icon
11187
Outlook Therapeutics
OTLK
$141M
$270K ﹤0.01%
6,225
+2,408
+63% +$116K
PGEN icon
11188
PUT
Precigen
PGEN
$2.18B
$270K ﹤0.01%
54,200
-21,600
-28% -$124K
HTT
11189
PUT
High Templar Tech Ltd
HTT
$393M
$270K ﹤0.01%
185,200
-48,500
-21% -$85.1K
SCHB icon
11190
PUT
Schwab US Broad Market ETF
SCHB
$45.1B
$270K ﹤0.01%
15,600
+600
+4% +$10.7K
VSTM icon
11191
Verastem
VSTM
$596M
$270K ﹤0.01%
7,313
-18,418
-72% -$677K
WOW
11192
DELISTED
WideOpenWest
WOW
$270K ﹤0.01%
13,739
-281,272
-95% -$5.89M
ZVRA icon
11193
Zevra Therapeutics
ZVRA
$672M
$270K ﹤0.01%
28,978
+812
+3% +$8.19K
TRAW icon
11194
Traws Pharma
TRAW
$8.7M
$270K ﹤0.01%
+2,824
New +$364K
SEEL
11195
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$270K ﹤0.01%
29
-8
-22% -$68.8K
ERM
11196
DELISTED
EquityCompass Risk Manager ETF
ERM
$270K ﹤0.01%
10,942
– –
INOV
11197
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$270K ﹤0.01%
6,700
-18,100
-73% -$684K
BW icon
11198
CALL
Babcock & Wilcox
BW
$1.53B
$269K ﹤0.01%
42,000
+14,100
+51% +$98.4K
ILPT
11199
PUT
Industrial Logistics Properties Trust
ILPT
$595M
$269K ﹤0.01%
10,600
-7,200
-40% -$192K
IYZ icon
11200
iShares US Telecommunications ETF
IYZ
$1.23B
$269K ﹤0.01%
+8,300
New +$280K
446 447
448
449 450

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.